The maker of Viagra and the advanced breast cancer drug Ibrance has been dealing with shifting risks from the loss of patent protections for key products, like other drugmakers. For Pfizer, those drugs include the cholesterol pill Lipitor. The New York company said in July that it was reshaping its business into three units: Innovative Medicines; Established Medicines, which handles older drugs that have lost protection; and Consumer Healthcare.